###### Editor\'s key points

The ASA physical status classification was designed as a measure of preoperative health status, not operative risk.This study found good agreement with how different anaesthetists rate a patient\'s ASA classification.This study used psychometric methods to show that the ASA classification is an indicator of perioperative risk.

The ASA physical status (ASA-PS) scale is commonly used to subjectively estimate preoperative health status. While originally created for statistical data collection and reporting in anaesthesia,^[@AEU100C1]^ it is now used for allocating resources,^[@AEU100C2]^ reimbursing anaesthesia services,^[@AEU100C3]^ and predicting perioperative risk.^[@AEU100C4]--[@AEU100C15]^

Inter-rater reliability is important when assessing the ASA-PS.^[@AEU100C16]^ Most reliability studies of the ASA-PS involved different anaesthesiologists rating *hypothetical* case scenarios. These studies found only fair inter-rater agreement (*κ* 0.21--0.4), thus raising concerns about the scale\'s reliability.^[@AEU100C17]--[@AEU100C21]^ There has been little evaluation of its reliability in clinical practice. In a multicentre study involving 1357 anaesthesia records,^[@AEU100C22]^ the ASA-PS score assigned by the responsible anaesthesiologist had moderate agreement (*κ* 0.53) with the score assigned by another blinded anaesthesiologist who had reviewed a duplicate version of the same medical record.^[@AEU100C22]^ A similar single-centre study of 430 paediatric anaesthesia records found low-to-moderate reliability (*κ* 0.43).^[@AEU100C12]^

Given the paucity of relevant data, we undertook a cohort study to characterize the reliability and validity of the ASA-PS scale in clinical practice. The primary objective was to evaluate the inter-rater agreement of ASA-PS scores assigned at outpatient preoperative assessment clinics *vs* operating theatres. The secondary objectives were to assess the scale\'s validity as a measure of health status by measuring its association with patient characteristics, validated predictive indices \[Charlson comorbidity index^[@AEU100C23]^ and revised cardiac risk index (RCRI)\],^[@AEU100C11]^ hospital stay, complications, and mortality.

Methods {#s2}
=======

After research ethics board approval, we conducted a retrospective cohort study of consecutive adults aged ≥18 yr who underwent elective non-cardiac surgery from March 2010 to December 2011 at the University Health Network (Toronto, Ontario, Canada), a quaternary care medical centre offering all adult surgical services except trauma and obstetrics. The cohort included all individuals who underwent elective non-cardiac surgery within 30 days after outpatient assessment at the institutional preoperative assessment clinics. The research ethics board waived the requirement for written informed consent for this study.

Data sources {#s2a}
------------

At the preoperative clinics, nurses document histories using a structured electronic questionnaire (Clinical Anesthesia Information System PreOp Clinic, Adjuvant Informatics, Flamborough, Ontario, Canada) that captures age, sex, comorbidities, and medications in a linkable data set.^[@AEU100C24]^ Each record includes an ASA-PS score assigned by the anaesthesiologist in the clinic (Table [1](#AEU100TB1){ref-type="table"}). Case records from the clinic database were linked to the Enterprise Electronic Data Warehouse (EDW), which captures all information recorded by the hospital electronic charting system (MISYS EPR; Quadramed Corporation, Reston, VA, USA). The EDW includes information on surgeries, laboratory tests, in-hospital medications, hospital length-of-stay, in-hospital mortality, and *International Classification of Diseases* 10th Revision (ICD-10) diagnostic codes. Documented surgical information includes an ASA-PS score assigned by the anaesthesiologist in the operating theatre. Table 1Description of ASA-PS classesASA-PS classDescriptionClass IA normal healthy patientClass IIA patient with mild systemic diseaseClass IIIA patient with severe systemic diseaseClass IVA patient with severe systemic disease that is a constant threat to lifeClass VA moribund patient who is not expected to survive without operationClass VIA declared brain-dead patient whose organs are being removed for donation

The primary variables of interest were ASA-PS scores assigned in the preoperative clinics and operating theatres. Patients\' age, sex, surgery, preoperative creatinine concentration, hospital length of stay, in-hospital 30 day mortality, and postoperative myocardial injury (troponin I concentration exceeding 0.30 μg litre^−1^) were captured from the EDW. We ascertained specific comorbidities using the clinic data set (hypertension, coronary artery disease, heart failure, diabetes, cerebrovascular disease, asthma, chronic obstructive pulmonary disease) and EDW (Charlson comorbidity index).^[@AEU100C23][@AEU100C25]^ We calculated the RCRI score using information from the EDW (surgical procedure and preoperative creatinine concentration) and clinic data set (other comorbidities).^[@AEU100C11]^

Contextual factors {#s2b}
------------------

Several factors should be considered when comparing ASA-PS ratings in operating theatres *vs* preoperative clinics at the University Health Network. *First*, it is possible that an individual patient received care from the same anaesthesiologist in the clinic and operating theatre. Such scenarios were uncommon given the ∼65 consultant anaesthesiologists at the institution. *Secondly*, anaesthesiologists in operating theatres were not blinded to ASA-PS assessments performed in the clinics. Blinding was not feasible since clinic assessments are part of routine clinical care. Nonetheless, anaesthesiologists in operating theatres typically pay little attention to the clinic rating, which is reported as a single non-highlighted line in an extensive computer-generated report. *Thirdly*, anaesthesiologists in operating theatres (but not clinics) receive financial premiums from the government health insurance plan to provide anaesthetic care to ASA-PS class III or class IV patients. These premiums were paid by to the anaesthesiologists\' group practice plan, and hence shared among all its members.

Analysis {#s2c}
--------

Analyses were performed using STATA version 13 (StataCorp Inc., Lakeway, TX, USA) and the R statistical language.^[@AEU100C26]^ A two-tailed *P*-value of \<0.05 was used to define statistical significance.

*Reliability* refers to the reproducibility of an instrument, with inter-rater reliability referring to the application of the ASA-PS scale to the same group of patients by different raters. We measured agreement of ASA-PS ratings assigned in the clinic *vs* operating theatre using the intra-class correlation coefficient (ICC) and Cohen\'s weighted *κ*. Landis and Koch^[@AEU100C27]^ characterize reliability statistic values of 0--0.20 as 'slight', 0.21--0.4 as 'fair', 0.41--0.60 as 'moderate', 0.61--0.80 as 'substantial', and values exceeding 0.80 as 'almost perfect'. McHorney and Tarlov^[@AEU100C28]^ have also suggested that the ICC for measures applied to individual patients should exceed 0.90. We conducted two sensitivity analyses. *First*, we re-calculated the ICC after excluding successive randomly selected patients whose raters agreed on ASA-PS classification. This analysis assessed how the lack of blinding impacted our results. This process was repeated until the ICC approached values reported by previous blinded studies.^[@AEU100C12][@AEU100C17]--[@AEU100C22]^ *Secondly*, we modified our study cohort such that the number of patients who were 'up-coded' in a financially advantageous manner (i.e. from class II to III, or from class III to IV) was equal to the number 'down-coded' in a financially disadvantageous manner (i.e. from class III to II, or from class IV to III). Any excess 'up-coded' patients were classified instead as having identical ratings in the clinic and operating theatre. The ICC was re-calculated in this hypothetical cohort to assess the influence of financial incentives for anaesthesiologists in operating theatres to assign patients to ASA-PS class III or IV.

We categorized each patient as being assigned (i) the same ASA-PS score assigned in the clinic and operating theatre, (ii) a lower score in the operating theatre, and (iii) a higher score in the operating theatre. We compared the characteristics of the categories using the *χ*^2^ test for categorical variables, and analysis of variance or the Kruskal--Wallis test for continuous variables. We also used multivariable logistic regression to determine the adjusted association of patient and surgery characteristics with inter-rater disagreement. The dependent variable was *any* disagreement in ASA-PS scores, while the predictor variables included age, surgery, and comorbidities. In the primary analysis, individual comorbidities were considered as separate predictor variables, while a sensitivity analysis instead considered the total number of concurrent systemic diseases as a predictor variable.

In the primary analysis, we assessed the validity of ASA-PS ratings in the clinic, while ratings in operating theatres were assessed in a secondary analysis. Both construct and criterion validity were evaluated. *Construct validity* refers to whether the ASA-PS scale behaves like a measure of preoperative physical status.^[@AEU100C29]^ For example, individuals with poorer physical status are likely to be older and have more comorbidity. We used descriptive statistics to characterize strata defined by ASA-PS rating. Categorical variables were described using counts and proportions, while continuous variables were described using means, standard deviations, medians, and inter-quartile ranges. We compared characteristics of these strata using the *χ*^2^ test for categorical variables, and analysis of variance or the Kruskal--Wallis test for continuous variables. The correlation of ASA-PS rating with age was further assessed using Spearman\'s *ρ*.

We also evaluated the criterion validity of the ASA-PS scale, which consists of concurrent and predictive validity. *Concurrent validity* refers to whether the scale correlates with other indices of health status measured at approximately the same time. Spearman\'s *ρ* was used to assess the correlation of ASA-PS ratings with the Charlson comorbidity index and RCRI scores. *Predictive validity* describes whether the ASA-PS scale predicts future-related events. For example, patients with poor health status are more likely to suffer postoperative morbidity and mortality. We used the area-under-the-curve (AUC) of the receiver-operating characteristic curve to separately measure the discrimination of ASA-PS ratings for the outcomes of in-hospital 30 day mortality and myocardial injury. Additionally, the correlation of ASA-PS ratings with hospital length-of-stay was measured using Spearman\'s *ρ*.

We used all available data from our databases within the study time frame (March 2010--December 2011). To place the available sample size in context, we estimated the sample size required to measure a plausible degree of inter-rater reliability with acceptable precision. The sample size required to measure an ICC of 0.41 (moderate agreement) with a lower two-sided 95% confidence interval (CI) excluding an ICC of 0.21 (fair agreement) with 90% power was 175.

Results {#s3}
=======

The cohort consisted of 10 864 patients (Table [2](#AEU100TB2){ref-type="table"}), of whom 5.5% (*n*=602) were assigned to ASA-PS class I, 42.0% (*n*=4562) assigned to class II, 46.7% (*n*=5073) assigned to class III, and 5.8% (*n*=627) assigned to class IV in the preoperative clinic. Table 2Characteristics of study cohort, stratified by ASA-PS rating. ENT, ear--nose--throat; [sd]{.smallcaps}, standard deviation. \*Defined as preoperative dialysis requirement or preoperative creatinine concentration exceeding 176 μmol litre^−1^ (2.0 mg dl^−1^) ASA-PS rating assigned in the preoperative assessment clinic*P*-valueI (*n*=602)II (*n*=4562)III (*n*=5073)IV (*n*=627)Patient characteristics Age (yr), mean (range)44.0 (18--99)58.0 (18--95)61.0 (18-95)66.0 (18--94)\<0.001 Male sex290 (48.2%)2107 (46.2%)2591 (51.1%)414 (66.0%)\<0.001Surgical service ENT surgery95 (15.8%)656 (14.4%)514 (10.1%)98 (15.6%) General surgery105 (17.4%)590 (12.9%)998 (19.7%)118 (18.8%) Gynaecology49 (8.1%)416 (9.1%)367 (7.2%)46 (7.3%) Neurosurgery11 (1.8%)271 (5.9%)592 (11.7%)20 (3.2%) Ophthalmology0 (0.0%)2 (0.0%)2 (0.0%)0 (0.0%)\<0.001 Orthopaedic surgery126 (20.9%)1330 (29.2%)1179 (23.2%)27 (4.3%) Plastic surgery35 (5.8%)169 (3.7%)80 (1.6%)5 (0.8%) Thoracic surgery13 (2.2%)257 (5.6%)585 (11.5%)121 (19.3%) Urology168 (27.9%)840 (18.4%)565 (11.1%)57 (9.1%) Vascular surgery0 (0.0%)31 (0.7%)191 (3.8%)135 (21.5%)Comorbid disease Coronary artery disease5 (0.8%)316 (6.9%)992 (19.6%)229 (36.5%)\<0.001 Congestive heart failure1 (0.2%)9 (0.2%)121 (2.4%)78 (12.4%)\<0.001 Peripheral vascular disease0 (0.0%)32 (0.7%)163 (3.2%)99 (15.8%)\<0.001 Cerebrovascular disease2 (0.3%)86 (1.9%)376 (7.4%)99 (15.8%)\<0.001 Hypertension16 (2.7%)1574 (34.5%)2736 (53.9%)409 (65.2%)\<0.001 Diabetes2 (0.3%)386 (8.5%)1143 (22.5%)185 (29.5%)\<0.001 Renal insufficiency\*0 (0%)5 (0.1%)118 (2.3%)47 (7.5%)\<0.001 Chronic obstructive pulmonary disease0 (0%)132 (2.9%)430 (8.5%)110 (7.5%)\<0.001 Asthma25 (4.2%)389 (8.5%)629 (12.4%)66 (10.5%)\<0.001 Rheumatic disease0 (0.0%)27 (0.6%)87 (1.7%)14 (2.3%)\<0.001 Peptic ulcer disease0 (0.0%)17 (0.4%)36 (0.7%)8 (1.3%)0.003 Liver disease4 (0.7%)70 (1.5%)168 (3.3%)35 (5.6%)\<0.001Cancer Primary disease118 (19.6%)1364 (29.9%)1331 (26.2%)172 (27.4%)\<0.001 Metastatic disease33 (5.5%)507 (11.1%)790 (15.6%)126 (20.1%)Comorbidity indices Charlson comorbidity index, mean ([sd]{.smallcaps})0.83 (1.79)1.59 (2.37)2.28 (2.70)3.25 (2.78)\<0.001 Revised cardiac risk index, mean ([sd]{.smallcaps})0.21 (0.42)0.36 (0.57)0.88 (0.88)1.61 (1.13)\<0.001Outcomes Postoperative myocardial injury0 (0.0%)19 (0.4%)56 (1.1%)28 (4.5%)\<0.001 30 day in-hospital mortality0 (0.0%)11 (0.2%)25 (0.5%)15 (2.4%)\<0.001 Hospital length of stay (mean, [sd]{.smallcaps})3.0 (2.7)4.0 (5.3)6.0 (8.9)8.0 (11.2)\<0.001

Inter-rater reliability {#s3a}
-----------------------

The agreement between ASA-PS scores assigned in the preoperative clinic *vs* operating theatre is presented in Table [3](#AEU100TB3){ref-type="table"} and Figure [1](#AEU100F1){ref-type="fig"}. Approximately 67% of individuals (*n*=7279) were assigned to the same ASA-PS class in the clinic and operating theatre, while 98.6% (*n*=10 712) of paired assessments were within one ASA-PS class of each other. Approximately 21% (*n*=2245) were assigned to a higher ASA-PS class in the operating theatre, while 12% (*n*=1340) were assigned to a lower class. Inter-rater reliability measured by the one-way ICC was 0.61 (95% CI, 0.60--0.62), while the weighted *κ* statistic was 0.61 (95% CI, 0.60--0.62). The calculated ICC approached values seen in prior unblinded studies if one-third to one-half of all cases of inter-rater agreement were excluded ([Supplementary Fig. S1](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aeu100/-/DC1)). When the study cohort was modified to remove the effects of any financial incentives for ASA-PS classification ([Supplementary Table S1](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aeu100/-/DC1)), the re-calculated ICC increased to 0.68 (CI, 0.67--0.69). Table 3Agreement between ASA-PS ratings in the preoperative assessment clinic *vs* operating theatreASA-PS rating in the operating theatreASA-PS rating assigned in the preoperative assessment clinicASA I (*n*=602)ASA II (*n*=4562)ASA III (*n*=5073)ASA IV (*n*=627)ASA I (*n*=515)285 (47.3%)201 (4.4%)28 (0.6%)1 (0.2%)ASA II (*n*=3905)264 (43.9%)2814 (61.7%)807 (15.9%)20 (3.2%)ASA III (*n*=5689)52 (8.6%)1497 (32.8%)3857 (76.0%)283 (45.1%)ASA IV (*n*=755)1 (0.2%)50 (1.1%)381 (7.5%)323 (51.5%) Fig 1Distribution of ASA-PS ratings in the operating theatre, within strata defined by ASA-PS rating in the preoperative assessment clinic.

In unadjusted analyses, inter-rater disagreement was associated with patient age, surgery, specific comorbidities (i.e. coronary artery disease, peripheral vascular disease, hypertension, asthma, cancer), and Charlson comorbidity index scores (Table [4](#AEU100TB4){ref-type="table"}). After multivariable adjustment, factors significantly associated with inter-rater disagreement were age, surgical procedure, hypertension, and malignancy (Table [5](#AEU100TB5){ref-type="table"}). Surgical procedures that were significantly less likely to be associated with inter-rater disagreement were general surgery, neurosurgery, orthopaedic, and urological procedures. In a sensitivity analysis, increased burden of comorbidity was associated with lower odds of inter-rater disagreement ([Supplementary Table S2](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aeu100/-/DC1)). Table 4Characteristics of categories defined by level of inter-rater agreement for ASA-PS rating. ENT, ear--nose--throat; [sd]{.smallcaps}, standard deviation. \*Defined as preoperative dialysis requirement or preoperative creatinine concentration exceeding 176 μmol litre^−1^ (2.0 mg dl^−1^)Lower ASA-PS rating in operating theatre \[*n*=1340 (12.3%)\]No change in ASA-PS rating \[*n*=7279 (67.0%)\]Higher ASA-PS rating in operating theatre \[*n*=2245 (20.7%)\]*P*-valuePatient characteristics Age (yr), mean (range)56.3 (18--94)59.1 (18--95)59.9 (18--99)\<0.001 Male sex681 (12.6%)3612 (66.9%)1110 (20.5%)0.69Surgical service ENT surgery261 (19.2%)803 (58.9%)299 (21.9%) General surgery206 (11.4%)1238 (68.4%)367 (20.3%) Gynaecology144 (16.4%)485 (55.2%)249 (28.4%) Neurosurgery74 (8.3%)676 (75.6%)144 (16.1%) Ophthalmology1 (25.0%)2 (50.0%)1 (25.0%) Orthopaedic surgery244 (9.2%)2063 (77.5%)355 (13.3%)\<0.001 Plastic surgery43 (14.7%)172 (59.5%)74 (25.6%) Thoracic surgery129 (13.2%)583 (59.7%)264 (27.1%) Urology202 (12.4%)1049 (64.4%)379 (23.3%) Vascular surgery36 (10.1%)208 (58.3%)113 (31.7%)Comorbid disease Coronary artery disease177 (11.5%)1077 (69.8%)288 (18.7%)0.04 Congestive heart failure28 (13.4%)141 (67.5%)40 (19.1%)0.82 Peripheral vascular disease24 (8.2%)176 (59.9%)94 (32.0%)\<0.001 Cerebrovascular disease70 (12.4%)393 (69.6%)101 (17.9%)0.25 Hypertension537 (11.3%)3277 (69.2%)921 (19.5%)\<0.001 Diabetes200 (11.7%)1189 (69.3%)327 (19.1%)0.09 Renal insufficiency\*18 (10.6%)116 (68.2%)36 (21.2%)0.78 Chronic obstructive pulmonary disease68 (10.1%)461 (68.6%)143 (21.3%)0.20 Asthma160 (14.4%)760 (68.5%)189 (17.0%)0.002 Rheumatic disease23 (18.0%)86 (67.2%)19 (14.8%)0.07 Peptic ulcer disease10 (16.4%)43 (70.5%)8 (13.1%)0.27 Liver disease32 (11.6%)178 (64.3%)67 (24.2%)0.82Malignancy Primary disease398 (13.3%)1821 (61.0%)766 (25.7%)\<0.001 Metastatic disease207 (14.2%)881 (60.5%)368 (25.3%)Comorbidity indices Charlson comorbidity index, mean ([sd]{.smallcaps})2.14 (2.68)1.82 (2.50)2.31 (2.72)\<0.001 Revised cardiac risk index, mean ([sd]{.smallcaps})0.64 (0.84)0.67 (0.85)0.68 (0.83)0.30 Table 5Adjusted association of patient characteristics with disagreement in ASA-PS class rating. ENT, ear--nose--throat. \*Defined as preoperative dialysis requirement or preoperative creatinine concentration exceeding 176 μmol litre^−1^ (2.0 mg dl^−1^)Adjusted odds ratio for disagreement in ASA rating95% confidence interval*P*-valuePatient characteristics Male sex1.040.95--1.140.40Age 40 yr or lessReference category 41--60 yr0.840.74--0.96 61--80 yr0.940.82--1.080.03 81 yr or more0.890.72--1.10Surgical service ENT surgeryReference category General surgery0.660.57--0.77 Gynaecology1.201.00--1.43 Neurosurgery0.460.38--0.55 Ophthalmology1.490.21--10.67\<0.001 Orthopaedic surgery0.420.36--0.48 Plastic surgery0.990.76--1.28 Thoracic surgery0.970.82--1.15 Urology0.880.75--0.92 Vascular surgery1.130.82--1.58Comorbid disease Coronary artery disease0.890.78--1.000.06 Congestive heart failure1.040.76--1.410.83 Peripheral vascular disease1.020.72--1.430.92 Cerebrovascular disease0.910.75--1.100.33 Hypertension0.860.78--0.940.001 Diabetes0.950.84--1.070.42 Renal insufficiency\*0.910.65--1.270.58 Chronic obstructive pulmonary disease0.880.74--1.050.15 Asthma1.010.88--1.150.93 Rheumatic disease1.250.86--1.840.25 Peptic ulcer disease0.920.52--1.620.77 Liver disease1.160.89--1.500.27Malignancy Primary disease1.201.07--1.340.002 Metastatic disease1.191.04--1.37

Validity {#s3b}
--------

The ASA-PS classes assigned in the clinic differed significantly with respect to age, sex, surgery, comorbidities, and composite comorbidity index scores (Table [2](#AEU100TB2){ref-type="table"}). In general, individuals in higher ASA-PS classes were likely to be older males with more comorbid disease and higher composite comorbidity index scores. These same individuals had longer stays in hospital, and also higher risks of postoperative mortality and myocardial injury (Table [2](#AEU100TB2){ref-type="table"}). The ASA-PS rating in the clinic was correlated with age (Spearman\'s *ρ*, 0.23; CI, 0.21--0.25), Charlson comorbidity index score (Spearman\'s *ρ*, 0.24; CI, 0.22--0.26), and RCRI score (Spearman\'s *ρ*, 0.40; CI, 0.38--0.42). The rating had moderate discrimination for predicting 30 day in-hospital mortality (AUC 0.69; CI, 0.62--0.76) and myocardial injury (AUC 0.70; CI, 0.65--0.75). It was weakly correlated with hospital length of stay (Spearman\'s *ρ*, 0.16; CI, 0.15--0.18).

In a secondary analysis, ASA-PS ratings in the operating theatre had higher correlations with age (Spearman\'s *ρ*, 0.28; CI, 0.26--0.29), Charlson comorbidity index (Spearman\'s *ρ*, 0.28; CI, 0.27--0.30), RCRI (Spearman\'s *ρ*, 0.42; CI, 0.41--0.44), and hospital length of stay (Spearman\'s *ρ*, 0.20; CI, 0.19--0.22). Ratings in the operating theatre had moderate ability to predict mortality (AUC 0.74; CI, 0.68--0.80) and myocardial injury (AUC 0.75; CI, 0.71--0.79). Compared with clinic ratings, ratings in the operating theatre differed significantly with respect to predicting myocardial injury (*P*=0.01) but not mortality (*P*=0.17).

Discussion {#s4}
==========

Given the ubiquity of the ASA-PS scale in clinical practice, it is important to define its reliability and validity. In this large single-institution study, the ASA-PS scale had moderate inter-rater reliability, despite its inherent subjectivity. Furthermore, it demonstrated validity as a measure of preoperative health status, showing expected patterns of association with patient characteristics and postoperative outcomes.

Poor reliability has been among the largest criticisms of the ASA-PS scale.^[@AEU100C17]--[@AEU100C21]^ For example, a previous study relying on hypothetical case scenarios found only fair inter-rater agreement (*κ* 0.21--0.4).^[@AEU100C19]^ Another study found moderate inter-rater agreement (*κ* 0.53) when instead comparing ratings by the responsible anaesthesiologist *vs* a different blinded anaesthesiologist reviewing the same medical record.^[@AEU100C22]^ In contrast to previous work, our study evaluated the inter-rater reliability of the ASA-PS scale in 'real-world' clinical practice. Since we compared ASA-PS ratings performed by two anaesthesiologists involved in the clinical care of the same patient, both raters had the opportunity to interview, physically examine, and participate in clinical decision-making. This increased degree of clinical engagement may have explained, in part, the higher observed inter-rater reliability. This degree of inter-rater agreement is remarkable for a subjective rating scale, with 67% of patients being assigned the same ASA-PS score, and almost 99% being assigned scores within one ASA-PS class of each other.

Despite the increased degree of inter-rater reliability in our present study, the ICC (0.61) and weighted *κ* (0.61) still decreased below the minimum of 0.90 recommended by McHorney and Tarlov.^[@AEU100C28]^ The absence of high inter-rater reliability is also not surprising. There is inherent subjectivity to differentiating between patients with 'mild systemic disease', 'severe systemic disease', and 'severe systemic disease that is a constant threat to life', especially in the absence of a 'moderate systemic disease' category or further standardized information to help define the current existing categories.

We identified several factors associated with inter-rater disagreement, namely age, surgery, hypertension, malignancy, and comorbidity burden. Age has been previously noted as a source of disagreement in ASA-PS ratings,^[@AEU100C20]^ especially since there are no guidelines on how patients\' age should be considered when assigning ASA-PS scores. Nonetheless, the association between age and inter-rater disagreement in our study should be viewed cautiously since its statistical significance was not strong. Additionally, the association did not follow a logical pattern, such as increasing inter-rater disagreement at the extremes of age. Surgical procedure has also previously been identified as a source of inter-rater disagreement.^[@AEU100C17][@AEU100C18]^ For example, Haynes and Lawler^[@AEU100C18]^ found that anaesthesiologists assigned patients undergoing minor surgical procedures to lower ASA-PS classes than would be otherwise expected, even when the patients had serious medical disease. The influence of surgical procedure on inter-rater disagreement is likely driven by misunderstanding of the ASA-PS classification system, which was developed to measure preoperative health status, not operative risk. Indeed, in his original paper, Saklad^[@AEU100C1]^ stated that the ASA-PS grade had 'no relation to the operative procedure, the ability of the surgeon or anesthetist, nor the type of anesthesia the patient will receive'. Nonetheless, many anaesthesia providers still consider the ASA-PS scale an anaesthetic risk predictor.^[@AEU100C17]^ The association of specific comorbidities with inter-rater disagreement in our study has some consistency with previous research.^[@AEU100C22]^ In addition, our results suggest that clinicians are less likely to agree on how some medical conditions (e.g. cancer) impact on preoperative physical status, but more likely to agree on the impact of the total burden of comorbidity.

In addition to evaluating the reliability of the ASA-PS scale, we assessed its construct, concurrent, and predictive validity.^[@AEU100C29]^ The scale showed construct validity, based on fair correlation with patient age, and an increased burden of comorbidities in patients with higher ASA-PS scores (Table [2](#AEU100TB2){ref-type="table"}). Our findings confirm previous work, such as a single-centre study showing strong interdependence between ASA-PS ratings and National Surgical Quality Improvement Program clinical risk factors.^[@AEU100C7]^ The ASA-PS scale also exhibited concurrent validity. It was correlated with more 'objective' comorbidity indices such as the Charlson comorbidity index, and RCRI. Notably, the correlation of ASA-PS scores with the Charlson comorbidity index was only slight-to-fair in magnitude. The relatively poor correlation may be explained by the subjectivity of the ASA-PS scale, and differences in how the two scales were developed. The ASA-PS scale was intended to measure preoperative physical status, while the Charlson comorbidity index was developed to measure risks of 1 yr mortality in medical inpatients.^[@AEU100C1][@AEU100C23]^ These findings with respect to correlation with other comorbidity measures are consistent with previous research, such as a single-centre study showing correlation of the ASA-PS scale with the Neurological, Airway, Respiratory, Cardiovascular, and Other model of risk assessment in children.^[@AEU100C12]^

Our study confirmed the predictive validity of the ASA-PS scale. Even when assessed well before surgery in an outpatient clinic, the scale had moderate ability to predict postoperative mortality and cardiac complications. By comparison, its correlation with hospital length of stay was relatively weak, likely because hospital length of stay is influenced by many distinct clinical factors, such as surgery type. The ability of the ASA-PS scale to predict adverse outcomes has previously been observed for specific surgeries,^[@AEU100C4][@AEU100C5][@AEU100C7][@AEU100C9][@AEU100C10][@AEU100C13]^ where higher ASA-PS scores were associated with higher mortality rates.^[@AEU100C14][@AEU100C15]^ It has also shown modest ability to predict postoperative cardiac complications,^[@AEU100C11][@AEU100C30]^ and been an important component of models designed to predict postoperative mortality and morbidity.^[@AEU100C6][@AEU100C8][@AEU100C31]^ This consistent demonstration of moderate predictive validity by the ASA-PS scale, both in our present study and previous research, supports its use as a component of risk-adjustment models for comparing surgical outcomes across hospitals. The ASA-PS score is incorporated into the risk-adjustment model used by the National Surgical Quality Improvement Program to measure the quality of surgical care across US hospitals.^[@AEU100C32][@AEU100C33]^

Notably, we found that the ASA-PS rating in operating theatres exhibited better validity, based on higher correlations with age, comorbidity scores, and hospital length of stay, and also improved prediction of myocardial injury. In some cases, its superior predictive validity could be explained by changes in a patient\'s medical status between the clinic visit and subsequent surgery. Nonetheless, such cases should be rare since the cohort only included elective surgeries performed within 30 days of a preoperative clinic visit. The superior predictive validity may also have been due to anaesthesiologists in operating theatres being less 'blinded' to eventual outcomes than those in the clinic. For example, patients assigned to class II in the clinic may have been re-assigned to class III in the operating theatre if they develop severe intraoperative hypotension. Nonetheless, such differences in 'blinding' cannot explain the higher correlation of ASA-PS ratings in the operating theatre with age and comorbidity indices. Thus, our findings indicate that ASA-PS ratings have the greatest validity when assigned by the responsible anaesthesiologist in the operating theatre. The results also highlight potential limitations of using hypothetical case scenarios or reviews of medical records as models for evaluating the psychometric properties of the ASA-PS scale.

Several study limitations need to be acknowledged. *First*, this was a retrospective cohort study from a single quaternary-care teaching institution, as reflected by the high proportion of ASA III and ASA IV patients. Similar studies at other centres with differing case-mixes are necessary to better generalize our findings. *Secondly*, the cohort only included patients who underwent elective surgery after being assessed in an outpatient preoperative assessment clinic. Thus, the cohort excluded individuals who were assigned ASA-PS class V, class VI, or any emergency modifier ('E') code. Our findings therefore cannot be extrapolated to non-elective surgical procedures. *Thirdly*, anaesthesiologists in operating theatres were not blinded to ASA-PS scores assigned in the clinic, thereby potentially biasing patients\' second ASA-PS rating and increasing inter-rater reliability. Nonetheless, this limitation permitted both anaesthesiologists to be able to conduct a face-to-face assessment of patients in a manner consistent with clinical practice. Indeed, the increased inter-rater agreement observed in our present study may be a reflection of anaesthesiologists being able to interview, physically examine, and participate in the medical care of patients, as opposed to reviewing hypothetical case scenarios or blinded medical charts. Furthermore, our sensitivity analysis suggests that these results would only be negated if fully one-third to one-half of all cases of inter-rater agreement were solely attributable to the lack of blinding. We would propose that such a large impact is unlikely. *Fourthly*, there were financial incentives to assign patients in operating theatres to ASA-PS classes III and IV. Nonetheless, since such incentives would encourage ratings in the operating theatre to disagree with ASA-PS scores assigned in the clinic, this bias would have led to an underestimate of reliability, as evidenced by our sensitivity analysis. The strength of the bias is also likely small, as individual financial premiums would be considerably diluted within a group practice plan of 65 consultant anaesthesiologists. Furthermore, previous research found no systematic differences in ASA-PS scores assigned by anaesthesiologists who used these scores for billing purposes, as opposed to scores assigned by anaesthesiologists who did not.^[@AEU100C20]^

Conclusions {#s5}
===========

In a large single-institution cohort study, the ASA-PS scale had moderate inter-rater reliability in clinical practice. The scale also showed validity, based on its correlation with preoperative characteristics and its prediction of postoperative outcomes. Despite the inherent subjectivity of the ASA-PS scale, our findings support its use as a measure of preoperative health status.
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